Xiao-Xi Lv

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Cancer Stem Cells

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cheng Zhang, Jiao-Jiao Yu, Chen Yang, Zhen-Long Yuan, Hui Zeng, Jun-Jian Wang, Shuang Shang, Xiao-Xi Lv, Xiao-Tong Liu, Jing Liu, Qi Xue, Bing Cui, Feng-Wei Tan, Fang Hua
Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway. Science translational medicine 15 (726) (2023)